| 131817BR | |
| Pharma | |
| Pharma - Oncology | |
| Canada | |
| Toronto | |
| Novartis Pharma Canada | |
| Development & Medical | |
| Oncology | |
| Full Time | |
| Temporary | |
| Job Purpose Ensure that clinical trials are conducted in Canada according to Novartis SOPs, Health Authority regulations and Good Clinical Practice. Major Accountabilities Assist in identifying potential investigators for clinical trials; Conduct site selection visit and appropriately assess adequacy of site personnel and facilities to conduct clinical trials; Conduct site initiation visits and train site personnel on study conduct, use of trial related tools (e.g. Case Report Form (CRF) completion) and adherence to Good Clinical Practice (GCP); Ensure patient recruitment strategies are in place and work with investigational sites to meet recruitment goals; Conduct regular monitoring visits as per Monitoring Plan to ensure patient safety, data integrity and compliance with protocol, GCP and local regulations. Address issues and follow them until completion / escalate issues if necessary; Ensure proper management, accountability and tracking of Clinical Trial Drug Supplies; Conduct Close-out visit and inform investigators of responsibilities; Act as primary contact for investigational sites under his / her responsibility. | |
| Education : B.Nursing, B.Sc., M.Sc., B.Pharm., PhD, MD Years of experience: 2+ years in clinical research Other: Strong knowledge of Good Clinical Practice and local regulations; Solid clinical background to ensure appropriate comprehension of study indications, study protocols and study related material; Strong organization and prioritization skills in order to respond to constantly changing situations and work on multiple projects; Strong interpersonal, communication and customerservicing skills; Previous clinical research experience (as CRA or as a site Clinical Coordinator) is an asset. Apply |
Wednesday, 29 January 2014
Position Title Clinical Research Associate, Oncology (Toronto) - 18 months
Posted by Unknown on 01:05 with No comments
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment